# Eli Lilly and Company (LLY) — Q3-2012 Earnings Results

**Report date:** 2012-10-24 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q3-2012

## Post-Earnings Brief

### Headline

Eli Lilly Misses on EPS, Stock Down 2.72%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.79 | N/A | -4.59% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based solely on numerical results.

### Guidance Changes

No guidance data is available.

### What It Means

Eli Lilly's earnings report showed a slight miss on EPS, which led to a 2.72% decline in the stock price. Investors may be concerned about the company's performance, especially since no revenue figures or guidance updates were provided. The lack of additional context from management could contribute to uncertainty among investors.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q3-2012_